Muhammad Ahsan Khan

Mr. Muhammad Ahsan Khan

COMSATS University Islamabad

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
KUKaleem Ullah
Kaleem Ullah
MSMuhammad Sohail
Muhammad Sohail
MBManal Ali Buabeid
Manal Ali Buabeid
GMGhulam Murtaza
Ghulam Murtaza
AUAziz Ullah
Aziz Ullah
YFYu Fang
Yu Fang

14 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ZKzaheer ullah khan
zaheer ullah khan
ARAnam Razzaq
Anam Razzaq
MKMuhammad Ahsan Khan
Muhammad Ahsan Khan
NRNaeem Ur Rehman
Naeem Ur Rehman
HKHira Khan
Hira Khan
NKNaveed Ullah Khan
Naveed Ullah Khan
Pentazocine (PTZ), a narcotic-antagonist analgesic, has been extensively used in the treatment of initial carcinogenic or postoperative pain. Hepatic first-pass metabolism results in low oral bioavailability and high dose wastage. Herein, 10 mg (-)-Pentazocine (HPLC-grade) was incorporated to solid lipid nanoparticles (SLNs) using a double water-oil-water (w/o/w) emulsion by solvent emulsification–evaporation technique, followed by high shear homogenization to augment its oral bioavailability, considering the lymphatic uptake. The resulting SLNs were characterized for zeta potential (ZP), particle size (PS), and polydispersity index (PDI) using a zetasizer. The entrapment efficiency (EE) and loading capacity (LC) were calculated. Chemical interactions, through the identification of active functional groups, were assessed by Fourier-transformed infrared (FTIR) spectroscopy. The nature (crystallinity) of the SLNs was determined by X-ray diffractometry (XRD). The surface morphology was depicted by transmission electron microscopy (TEM). In vitro (in Caco-2 cells) and in vivo (in male Wistar rats) investigations were carried out to evaluate the PTZ release behavior and stability, as well as the cellular permeation, cytotoxicity, systemic pharmacokinetics, antinociceptive, anti-inflammatory, and antioxidative activities of PTZ-loaded SLNs, mainly compared to free PTZ (marketed conventional dosage form). The optimized PTZ-loaded SLN2 showed significantly higher in vitro cellular permeation and negligible cytotoxicity. The in vivo bioavailability and pharmacokinetics parameters (t1/2, Cmax) of the PTZ-loaded SLNs were also significantly improved, and the nociception and inflammation, following carrageenan-induced inflammatory pain, were markedly reduced. Concordantly, PTZ-loaded SLNs showed drastic reduction in the oxidative stress (e.g., malonaldehyde (MDA)) and proinflammatory cytokines (e.g., Interleukin (IL)-1β, -6, and TNF-α). The histological features of the paw tissue following, carrageenan-induced inflammation, were significantly improved. Taken together, the results demonstrated that PTZ-loaded SLNs can improve the bioavailability of PTZ by bypassing the hepatic metabolism via the lymphatic uptake, for controlled and sustained drug delivery.
1

15 May 2019 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
SYSabine Adeline Fanta Yadang
Sabine Adeline Fanta Yadang
GTGermain Sotoing Taiwe
Germain Sotoing Taiwe
KZKatoucha Sidoine Ngatcha Zouakeu
Katoucha Sidoine Ngatcha Zouakeu
MKMuhammad Ahsan Khan
Muhammad Ahsan Khan
GAGabriel Agbor Agbor
Gabriel Agbor Agbor
EBElisabeth Ngo Bum
Elisabeth Ngo Bum
Carissa edulis is a plant used in the management of oxidative stress and inflammatory related disorders such as malaria, rheumatism inflammation, and cardiovascular diseases. The present study evaluates the total phenolic content, antioxidant capacity (DPPH, ABTS, and FRAP), and the bioactive compounds present in the various extracts of C. edulis (HEC, MEC, AEC, and PC). An HPLC analysis determined the different compounds present in the extracts. High concentration of total phenolic content was observed in aqueous and methanolic extracts more than in the hydroethanolic extract though not significantly different. Flavonoids were higher in the hydroethanolic and methanolic extracts, respectively, with 14.84 mg RE/g extract and 12.02 mg RE/g extract. Tannins were also found in large amounts in the same two extracts with 26.76 mg TAE/g extract and 34.67 mg TEE/g extract. The percentage radical scavenging activity DPPH ranged between 58.63% and 94.67% for aqueous extract and for ABTS between 51.39% and 94.12% for the methanolic extract. The highest FRAP was obtained in the methanolic extract (6.73 g AAE/100 g extract). HPLC analysis revealed the presence of quercetin, rutin, and gallic acid in the different extracts. C. edulis represents a potential source of bioactive components with antioxidant capacity.

1 September 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CFCésaire Feudjio
Césaire Feudjio
NSNjateng Guy Sedar Singor
Njateng Guy Sedar Singor
KJKLANG MATHILDE JULIE
KLANG MATHILDE JULIE
MYMuhammad Yameen
Muhammad Yameen
MKMuhammad Ahsan Khan
Muhammad Ahsan Khan
JKJules-Roger Kuiate
Jules-Roger Kuiate
Phragmanthera capitata is a medicinal plant used in traditional medicine to treat several diseases, including diabetes. Its antioxidant properties and inhibitory effects on enzyme-carbohydrate digestion activities have been demonstrated. The present study aimed to provide data that can contribute to rationalizing the preparation of antioxidant and antidiabetic extracts from this plant. P. capitata (whole plant) growing on Persea americana was harvested at the fruiting stage. A response surface design-type central composite was applied to maximize the extraction yield, phenolic contents, and antioxidant and antidiabetic properties of the ethyl acetate extract of P. capitata. The influencing extraction factors were temperature, powder particle size, and solvent-to-powder ratio. The total phenolic content, total antioxidant capacity (TAC), DPPH scavenging ability, ferric reducing antioxidant power (FRAP), and antidiabetic (α-amylase and α-glucosidase inhibitory) effects of the extracts were determined using conventional methods. A temperature above 55C contributed to the degradation of the extract, which was reflected in the GC-MS profile by a significant reduction in the number of compounds it contained. The optimal conditions were defined as 24.42C for temperature, 250µm powder particle size, and 8.30 (v:w) solvent-to-powder ratio. This extraction protocol resulted in more than twice the extraction yield (3.05), TTC (62.30mg TAE/g), TAC (41.41mg AAE/g), FRAP (186.56mg AAE/g), and α-amylase (IC50 15.05µg/mL) and α-glucosidase (IC50 21.14µg/mL) inhibitory activities compared to our previous results. Additionally, these optimal conditions led experimentally to the extraction of higher phenolic content and to the attainment of higher antioxidant and antidiabetic activity, which closely matched the predicted values. Using these conditions, it is possible to prepare an antidiabetic phytomedicine from P. capitatathat can prevent oxidative stress complications. However, further complementary studies should be carried out considering other factors that influence the composition and pharmacological properties of the extract.

12 August 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MKMuhammad Ahsan Khan
Muhammad Ahsan Khan
KUKaleem Ullah
Kaleem Ullah
NRNisar Ur Rahman
Nisar Ur Rahman
AMArshad Mahmood
Arshad Mahmood
AMAnette Müllertz
Anette Müllertz
SKShujaat Ali Khan
Shujaat Ali Khan

23 February 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BABadriyah Shadid Alotaibi
Badriyah Shadid Alotaibi
MKMuhammad Ahsan Khan
Muhammad Ahsan Khan
KUKaleem Ullah
Kaleem Ullah
HYHaya Yasin
Haya Yasin
AMAbdul Mannan
Abdul Mannan
GMGhulam Murtaza
Ghulam Murtaza
Glipizide, a poor water-soluble drug belongs to BCS class II. The proposed work aimed to enhance the solubility of glipizide by preparing solid dispersions, using polyvinyl pyrrolidone (PVP) and polyethylene glycol (PEG). Solvent evaporation method was used for the preparation of glipizide solid dispersions. Solid dispersions were prepared in four different drug-to-polymer ratios i.e. 1:1, 1:2, 1:3 and 1:4. Mainly effect of three polymers (PVP K30, PVP K90 and PEG 6000) was evaluated on the solubility and dissolution of glipizide. The in-vitro dissolution of all prepared formulations was performed under pH 6.8 at 37°C using USP type II apparatus. In-vitro dissolution results revealed that the formulations having high concentrations of the polymer showed enhanced solubility. Enhancements in the solubility and rate of dissolution of the drug were noted in solid dispersion formulations compared to the physical blends and pure drug. Solid dispersions containing polyvinyl pyrrolidone exhibited a more favorable pattern of drug release compared to the corresponding solid dispersions with PEG. An increase in the maximum solubility of the drug within the solid dispersion systems was observed in all instances. Two solid dispersion formulations were optimized and formulated into immediate-release tablets, which passed all the pharmacopoeial and non-pharmacopoeial tests. Fourier transformed Infrared (FTIR) spectroscopy X-ray diffraction (XRD) and Differential scanning calorimetry (DSC) were used to indicate drug: polymer interactions in solid state. Analysis of the solid dispersion samples through characterization tests indicated the compatibility between the drug and the polymer.